Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Introducing a New Series: Immunotherapy Facts and Hopes.

Melero I, Sznol M, Tessmer MS, Whiteside TL, Wolchok JD.

Clin Cancer Res. 2018 Apr 15;24(8):1773-1774. doi: 10.1158/1078-0432.CCR-18-0408. Epub 2018 Feb 23. No abstract available.

PMID:
29476022
2.

Identification of a ubiquitin-binding interface using Rosetta and DEER.

Tessmer MH, Anderson DM, Pickrum AM, Riegert MO, Moretti R, Meiler J, Feix JB, Frank DW.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):525-530. doi: 10.1073/pnas.1716861115. Epub 2018 Jan 2.

3.

AACR Cancer Progress Report 2017: Harnessing Research Discoveries to Save Lives.

Tessmer MS, Flaherty KT.

Clin Cancer Res. 2017 Sep 15;23(18):5325. doi: 10.1158/1078-0432.CCR-17-2302. No abstract available.

PMID:
28916616
4.

Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding.

Fischer AW, Anderson DM, Tessmer MH, Frank DW, Feix JB, Meiler J.

ACS Omega. 2017 Jun 30;2(6):2977-2984. doi: 10.1021/acsomega.7b00349. Epub 2017 Jun 27.

5.

Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A2 (PLA2) Enzyme, ExoU.

Tessmer MH, Anderson DM, Buchaklian A, Frank DW, Feix JB.

J Biol Chem. 2017 Feb 24;292(8):3411-3419. doi: 10.1074/jbc.M116.760074. Epub 2017 Jan 9.

6.

AACR Cancer Progress Report 2016: Improving Lives Through Research.

Tessmer MS, Anderson KC.

Clin Cancer Res. 2016 Oct 1;22(19):4759. Epub 2016 Oct 2. No abstract available.

7.

Generalized propagation of light through optical systems. II. Numerical implications.

Tessmer M, Gross H.

J Opt Soc Am A Opt Image Sci Vis. 2015 Dec 1;32(12):2276-85. doi: 10.1364/JOSAA.32.002276.

PMID:
26831382
8.

Generalized propagation of light through optical systems. I. Mathematical basics.

Tessmer M, Gross H.

J Opt Soc Am A Opt Image Sci Vis. 2015 Feb 1;32(2):258-66. doi: 10.1364/JOSAA.32.000258.

PMID:
26366597
9.

Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.

Chan IH, Jain R, Tessmer MS, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm JB, Pierce RH, Yearley JH, McClanahan TK, Phillips JH, Cua DJ, Bowman EP, Kastelein RA, LaFace D.

Mucosal Immunol. 2014 Jul;7(4):842-56. doi: 10.1038/mi.2013.101. Epub 2013 Nov 27.

PMID:
24280935
10.

IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.

Adamopoulos IE, Tessmer M, Chao CC, Adda S, Gorman D, Petro M, Chou CC, Pierce RH, Yao W, Lane NE, Laface D, Bowman EP.

J Immunol. 2011 Jul 15;187(2):951-9. doi: 10.4049/jimmunol.1003986. Epub 2011 Jun 13.

11.

Salivary gland NK cells are phenotypically and functionally unique.

Tessmer MS, Reilly EC, Brossay L.

PLoS Pathog. 2011 Jan 13;7(1):e1001254. doi: 10.1371/journal.ppat.1001254.

12.

[Agomelatine].

Tessmer M.

Med Monatsschr Pharm. 2009 Aug;32(8):282-8. Review. German.

PMID:
19777735
13.

NKT cell immune responses to viral infection.

Tessmer MS, Fatima A, Paget C, Trottein F, Brossay L.

Expert Opin Ther Targets. 2009 Feb;13(2):153-62. doi: 10.1517/14712590802653601 . Review.

14.

Cutting edge: Priming of NK cells by IL-18.

Chaix J, Tessmer MS, Hoebe K, Fuséri N, Ryffel B, Dalod M, Alexopoulou L, Beutler B, Brossay L, Vivier E, Walzer T.

J Immunol. 2008 Aug 1;181(3):1627-31.

15.

NK cell-like behavior of Valpha14i NK T cells during MCMV infection.

Wesley JD, Tessmer MS, Chaukos D, Brossay L.

PLoS Pathog. 2008 Jul 18;4(7):e1000106. doi: 10.1371/journal.ppat.1000106.

16.

A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo.

Guia S, Cognet C, de Beaucoudrey L, Tessmer MS, Jouanguy E, Berger C, Filipe-Santos O, Feinberg J, Camcioglu Y, Levy J, Al Jumaah S, Al-Hajjar S, Stephan JL, Fieschi C, Abel L, Brossay L, Casanova JL, Vivier E.

Blood. 2008 May 15;111(10):5008-16. doi: 10.1182/blood-2007-11-122259. Epub 2008 Mar 4.

17.

A Y chromosome-linked factor impairs NK T development.

Wesley JD, Tessmer MS, Paget C, Trottein F, Brossay L.

J Immunol. 2007 Sep 15;179(6):3480-7.

18.

KLRG1 binds cadherins and preferentially associates with SHIP-1.

Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay L.

Int Immunol. 2007 Apr;19(4):391-400. Epub 2007 Feb 16.

PMID:
17307799
19.

Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.

Robbins SH, Tessmer MS, Van Kaer L, Brossay L.

Eur J Immunol. 2005 Mar;35(3):757-65.

20.

Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection.

Robbins SH, Tessmer MS, Mikayama T, Brossay L.

J Immunol. 2004 Jul 1;173(1):259-66.

21.

Sequence-dependent conformational differences of small RNAs revealed by native gel electrophoresis.

Beuning PJ, Tessmer MR, Baumann CG, Kallick DA, Musier-Forsyth K.

Anal Biochem. 1999 Sep 10;273(2):284-90.

PMID:
10469499
22.
23.

Role of tryptophan-14 in the interaction of dynorphin A(1-17) with micelles.

Tessmer MR, Kallick DA.

J Pept Res. 1997 May;49(5):427-31.

PMID:
9211224
24.

NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles.

Tessmer MR, Kallick DA.

Biochemistry. 1997 Feb 25;36(8):1971-81.

PMID:
9047294
25.

The use of dodecylphosphocholine micelles in solution NMR.

Kallick DA, Tessmer MR, Watts CR, Li CY.

J Magn Reson B. 1995 Oct;109(1):60-5.

PMID:
8581309

Supplemental Content

Loading ...
Support Center